CATX

Perspective Therapeutics Inc

$3.10

-0.06 (-1.9%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 02.09.2026
$12.53
(+304.19%)
Strong Buy: 2
Buy: 12
Hold: 1
Sell: 0
Strong Sell: 0
Description:
Perspective Therapeutics Inc. (CATX) is a pioneering biotechnology firm focused on revolutionizing cancer care through the development of innovative radiopharmaceuticals. Leveraging state-of-the-art radioisotope technologies, CATX seeks to enhance the precision and effectiveness of cancer therapies, aiming to significantly improve patient survival rates across various malignancies. Backed by a seasoned leadership team and strong strategic alliances, the company is strategically positioned to drive advancements in targeted cancer treatments, addressing significant healthcare challenges in a competitive landscape.
Exchange:
AMEX
Country:
USA
Sector:
HEALTHCARE
Industry:
MEDICAL DEVICES
Address:
2401 ELLIOTT AVENUE, SEATTLE, WA, UNITED STATES, 98121
Fiscal year end:
December
Market capitalization:
$361 Million
EBITDA:
-$121 Million
PERatio:
0.0
EPS:
-1.35
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.799

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-56%
How much will you get:
$439
Prices dates:
31-08-2016: $7.20 and 31-08-2026: $3.16